June 20, 2026 10:02 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Italy and I never beg': Meloni fires back at Trump over G7 photo claim | No more 'brother': Stalin's formal birthday greeting to Rahul reflects deepening rift | TMC seeks disqualification of 20 rebel MPs, Abhishek says 'membership should go' | Nara Lokesh pitches Andhra Pradesh as investment hub during Kolkata visit, sets $2.4 trillion economy goal | 'Least restrictive option': Setback for Telegram as Delhi HC backs Centre's ban ahead of NEET-UG re-test | Fortuner torched, BJP leaders burnt alive: Sand mining feud ends in triple murder in Chhattisgarh | 'If Modi is the leader and India is attacked, we'll be there': Trump's strong assurance at G7 | 'Safety of Indian seafarers of utmost importance': PM Modi's strong message to Trump at G7 | Trump says Iran deal 'not final', threatens fresh strikes if Tehran ‘doesn’t behave’ | G7 declares war on global drug cartels, unveils major anti-trafficking plan

HSI India and PFA welcome India decision to end repeat animal testing of drugs

| | Mar 18, 2016, at 06:47 pm
New Delhi, Mar 18 (Just Earth News/IBNS) Leading animal protection organizations Human Society International (HSI) and People for Animal (PFA) on Friday lauded the move by the Union Ministry of Health and Family banning repeat animal testing of new drugs already tested abroad, thus sparing cruelty to thousands of animals.

The ban falls under amendment Schedule Y, in the Appendix I, under item 4 where after sub-item 4.8, the following note shall be inserted - “Where the data on animal toxicity as per the specifications of Appendix III has been submitted and the same has been considered by the regulatory authority of the country which had earlier approved the drug, the animal toxicity studies shall not be required to be conducted in India except in cases where there are specific concerns recorded in writing.”

 Humane Society International/India and People for Animals welcomed the decision.

Gauri Maulekhi, HSI/India consultant and a trustee at People for Animals, said, “We welcome and laud this move by the Health Ministry. The new amendment will not only save thousands of animals every year from being subjected to redundant animal testing, it also marks the beginning of a potential new era of sophisticated animal testing alternatives in India.

"We look forward to continuing our association with the Ministry to ensure that use of validated alternatives is encouraged as the Drug Technical Advisory Board has recommended.”

This move comes after Union Minister of Women & Child Development,  Maneka Sanjay Gandhi, wrote to the Ministry regarding the practice. The Investigational New Drug Committee, which considered the matter before the Drug Technical Advisory Board, states that if the drugs were tested elsewhere under Good Laboratory Practice conditions and align with India’s regulatory requirement, no further toxicity testing shall be required. Both committees also are encouraging the use of internationally accepted non-animal alternatives where available.

India has been a full adherent to the Organization for Economic Cooperation and Development decision regarding Mutual Acceptance of Data since 2011. As a consequence, the data generated by Indian Good Laboratory Practice laboratories must be accepted in all the OECD member countries, and vice-versa. The OECD estimates that adherence to MAD saves more than €150 million and scores of animals per year by avoiding needlessly duplicative testing. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.